Sirona Biochem Corp (SBM) — Cash Flow-to-Debt Ratio
Sirona Biochem Corp (SBM) has a Cash Flow-to-Debt Ratio of -0.13x as of July 2024, meaning its operating cash flow of CA$-552.59K could theoretically repay 0% of its total liabilities (CA$4.27 Million) in one year. See Sirona Biochem Corp free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sirona Biochem Corp Cash Flow-to-Debt Ratio (2011–2023)
Historical debt coverage capacity for Sirona Biochem Corp across 13 annual periods. For the full cash flow conversion analysis, see Sirona Biochem Corp cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Sirona Biochem Corp (2011–2023)
Year-by-year debt coverage analysis for Sirona Biochem Corp. Check SBM cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.50x | CA$-1.76 Million | CA$3.54 Million | ▲ +75.5% |
| 2022 | -2.02x | CA$-2.18 Million | CA$1.08 Million | ▼ -29.8% |
| 2021 | -1.56x | CA$-2.16 Million | CA$1.38 Million | ▼ -54.2% |
| 2020 | -1.01x | CA$-2.11 Million | CA$2.09 Million | ▲ +41.3% |
| 2019 | -1.72x | CA$-3.56 Million | CA$2.07 Million | ▼ -779.7% |
| 2018 | -0.20x | CA$-593.35K | CA$3.03 Million | ▲ +74.2% |
| 2017 | -0.76x | CA$-2.50 Million | CA$3.29 Million | ▲ +43.6% |
| 2016 | -1.35x | CA$-2.10 Million | CA$1.56 Million | ▲ +12.0% |
| 2015 | -1.53x | CA$-3.06 Million | CA$2.00 Million | ▼ -34.8% |
| 2014 | -1.14x | CA$-1.86 Million | CA$1.64 Million | ▲ +45.6% |
| 2013 | -2.09x | CA$-2.50 Million | CA$1.20 Million | ▲ +4.9% |
| 2012 | -2.20x | CA$-2.15 Million | CA$976.91K | ▲ +36.7% |
| 2011 | -3.47x | CA$-2.54 Million | CA$732.20K | — |